Abdominal Obesity-Metabolic Syndrome Clinical Trial
Official title:
Effect of a Meal Replacement on Weight Loss Obesity Patients With Metabolic Syndrome : A Randomized Controlled Trial
The purpose of this study is to determine whether meal replacement, SlimWell ®, is effective in the treatment of obesity patients with metabolic syndrome.
The participants are divided into two groups: intervention group and control group. In the
intervention group, the participants receive a meal replacement plus life style
modification. In the control group, the participants receive only life style modification.
Sample size calculation is 69 participants per group. Primary outcome is to compare the
weight loss between the intervention group and control group.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment